Analysen von Matthew Sykes
01.11.23 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
08.02.23 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
09.02.22 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
01.12.21 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
03.06.21 | QIAGEN Neutral | Goldman Sachs Group Inc. |